Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
791 Treatment patterns and real-world clinical outcomes of first-line anti-PD(L)1-based combination therapy among patients with non-squamous metastatic non-small cell lung cancer in Japan
Compose a Response to This Article
Other responses
No responses have been published for this article.
